Impact of exogenous antithrombin on low molecular weight heparin anti-Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort with variable antithrombin levels.

Beverly A SchaeferAdriane HausfeldMatthew MartinPaul SteeleJan MartinSandra R ReherAdam LaneLori Luchtman-Jones

Published in: Pediatric blood & cancer (2020)

Although LMWH levels from anti-Xa assays with added AT trend higher than in those without, correlation was fairly good between platforms in pediatric ALL/L plasmas, even when AT activity was <70%.

Keyphrases

young adults
high throughput
acute myeloid leukemia
bone marrow
venous thromboembolism
childhood cancer
growth factor
single cell